Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gustavo Dall'Olio F"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Claudia Parisi, Sebastiano Buti, Rita Golfieri, Stefano Brocchi, Alessandro Rizzo, Alessandro Leonetti, Paola Bordi, Filippo Gustavo Dall'Olio, Nicola Sverzellati, Andrea Ardizzoni, Gianluca Taronna, Marcello Tiseo
Introduction: Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) approved as first-line therapy for advanced EGFR-mutated non-small cell lung cancer (NSCLC). Some osimertinib-related interstitial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d3983ae1ccb0e9d89e77e5ec0b9ec41
http://hdl.handle.net/11585/851401
http://hdl.handle.net/11585/851401
Autor:
De Giglio A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: andrea.degiglio2@unibo.it., De Biase D; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy., Favorito V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Maloberti T; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Di Federico A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Zacchini F; Departmental Program in Laboratory Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Venturi G; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Parisi C; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Faculty of Medicine, Paris-Saclay University, Paris, France., Gustavo Dall'Olio F; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Ricciotti I; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Gagliano A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Melotti B; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Sperandi F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Altimari A; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Gruppioni E; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Tallini G; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Gelsomino F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Montanaro L; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Departmental Program in Laboratory Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Ardizzoni A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Dec 20; Vol. 199, pp. 108058. Date of Electronic Publication: 2024 Dec 20.
